SCHEMBL8689397

SCHEMBL8689397

CCCCCNCCc1ccc(-c2cc[nH]n2)cc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SIGMAR1 Q99720 4/20 0.53
▸ MAPT P10636 2/20 0.47
▸ HRH4 Q9H3N8 1/20 0.46
▸ HRH3 Q9Y5N1 1/20 0.46
▸ S1PR2 O95136 4/20 0.43
▸ S1PR1 P21453 4/20 0.43
▸ S1PR3 Q99500 4/20 0.43
▸ S1PR4 O95977 2/20 0.43
▸ SLC2A1 P11166 1/20 0.40
▸ SMN1; SMN2 Q16637 2/20 0.38
▸ RAB9A P51151 2/20 0.37
▸ L3MBTL1 Q9Y468 1/20 0.37
▸ CASP3 P42574 1/20 0.37
▸ SENP8 Q96LD8 1/20 0.37
▸ SENP7 Q9BQF6 1/20 0.37
▸ SENP6 Q9GZR1 1/20 0.37
▸ LPAR2 Q9HBW0 1/20 0.37
▸ CYP1A2 P05177 1/20 0.37
▸ CYP2D6 P10635 1/20 0.37
▸ CYP2C19 P33261 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23574683 0.84 MAPT (0.55) MAPTSMN1; SMN2RAB9AL3MBTL1CASP3
SCHEMBL8688772 0.80 SIGMAR1 (0.51) SIGMAR1MAPTHRH4HRH3S1PR2
SCHEMBL8692351 0.74 CYP1A2 (0.56) SIGMAR1HRH4HRH3S1PR2S1PR1
SCHEMBL10176696 0.73 METAP2 (0.55) MAPTSMN1; SMN2RAB9ALMNAALDH1A1
SCHEMBL8689692 0.72 CHRM2 (0.43) MAPTHRH4HRH3SMN1; SMN2CYP2D6
SCHEMBL8645556 0.71 CYP2D6 (0.56) MAPTSMN1; SMN2RAB9AL3MBTL1CYP1A2
SCHEMBL9405310 0.71 HRH3 (0.46) SIGMAR1MAPTHRH3LMNA
SCHEMBL28571095 0.71 TDP1 (0.39) MAPTTP53
SCHEMBL25701654 0.71 HRH4 (0.70) SIGMAR1HRH4HRH3S1PR2S1PR1
SCHEMBL13273800 0.71 SIGMAR1 (0.68) SIGMAR1HRH4HRH3S1PR2S1PR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5807860-A ACYLCOENZYME A:CHOLESTEROL ACYLTRANSFERASE INHIBITORS; HYPERLIPEMIA, ATHEROSCLEROSIS; ANTICHOLESTEROL AGENTS MITSUBISHI CHEMICAL CORPORATION (JP) 1998-09-15 — — US disclosed
EP-0773218-A1 N-(Piperazinylalkoxyphenyl)-N'phenylalkylurea derivatives as ACAT inhibitors for the treatment of atheroschlerosis MITSUBISHI CHEMICAL CORPORATION (JP) 1997-05-14 — — EP disclosed
Send feedback